Legal
Key facts
The release was published by Schall, Brown & Schwartz LLP through PR Newswire on Sept. 8,…
Key facts
The subject company is ARS Pharmaceuticals, Inc., also referred to as ARS, with ticker NASDAQ: SPRY
Key facts
The asserted legal claims are for violations of Section 10(b), Section 20(a), and SEC Rule 10b-5…
Atlas Watchline
Schall, Brown & Schwartz LLP said it is advising investors in a proposed securities-fraud class action…